PPA
ALDX icon

Parametric Portfolio Associates’s Aldeyra Therapeutics ALDX Stock Holding History

Parametric Portfolio Associates’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$553K Buy
124,299
+95,942
+338% +$382K ﹤0.01% 3054
2021
Q4 		$113K Sell
28,357
-2,827
-9% -$21.6K ﹤0.01% 3535
2021
Q3 		$274K Sell
31,184
-87,756
-74% -$805K ﹤0.01% 3333
2021
Q2 		$1.35M Buy
118,940
+92,171
+344% +$1.11M ﹤0.01% 2643
2021
Q1 		$318K Buy
26,769
+14,689
+122% +$169K ﹤0.01% 3692
2020
Q4 		$83K Sell
12,080
-3,413
-22% -$24K ﹤0.01% 3900
2020
Q3 		$115K Sell
15,493
-845
-5% -$5.46K ﹤0.01% 3769
2020
Q2 		$68K Sell
16,338
-2,121
-11% -$7.75K ﹤0.01% 3834
2020
Q1 		$46K Sell
18,459
-8,369
-31% -$37.6K ﹤0.01% 3842
2019
Q4 		$156K Buy
26,828
+10,907
+69% +$63K ﹤0.01% 3790
2019
Q3 		$84K Buy
+15,921
New +$85.7K ﹤0.01% 3854
2019
Q1 		– Sell
-92,816
Closed -$770K – 3925
2018
Q4 		$770K Buy
92,816
+15,298
+20% +$157K ﹤0.01% 3121
2018
Q3 		$1.07M Buy
+77,518
New +$629K ﹤0.01% 3050

Other funds holding ALDX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TLP
Tri Locum Partners New York $813M AUM 101.01% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Parametric Portfolio Associates's ALDX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Aldeyra Therapeutics (ALDX) stake by 338% in Q1 2022, buying an estimated $382K and bringing the position to 124,299 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

Parametric Portfolio Associates first reported a position in ALDX in Q3 2018 and has held it in 13 quarters since. The position peaked at $1.35M in Q2 2021. 111 funds tracked by Wall St. Rank hold ALDX as of Q1 2022.

  • Parametric Portfolio Associates held 124,299 shares of Aldeyra Therapeutics worth $553K as of Q1 2022.
  • Parametric Portfolio Associates bought 95,942 Aldeyra Therapeutics shares in Q1 2022, an estimated $382K.
  • Aldeyra Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3054 holding.
  • Parametric Portfolio Associates first reported a position in Aldeyra Therapeutics in Q3 2018 and has held it in 13 quarters since.
  • Parametric Portfolio Associates's Aldeyra Therapeutics position peaked at $1.35M in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.